- Enzyme Precursors
- Accession Number
Physiologically inactive substances that can be converted to active enzymes.
Drug Drug Description Drotrecogin alfa A form of recombinant activated human protein C used to reduce mortality in patients with severe sepsis by inhibiting coagulation Factors V and VIII. Prothrombin A coagulation factor used for emergency reversal of vitamin K antagonist therapy. Saruplase Not Annotated Protein C A medication used to treat protein C deficiency leading to purpura fulminans or coumarin-induced skin necrosis. Coagulation factor VIIa Recombinant Human A form of recombinant human coagulation Factor VII used to treat hemophilia A and B. Factor IX Complex (Human) A Factor IX complex used to prevent and treat bleeding episodes in hemophilia B or vitamin K antagonist therapy. Eftrenonacog alfa A recombinant Factor IX used to treat and prevent bleeding in hemophilia B. Vatreptacog alfa Vatreptacog Alfa (Activated) has been used in trials studying the treatment of Haemophilia B, Haemophilia A, Congenital Bleeding Disorder, Haemophilia A With Inhibitors, and Haemophilia B With Inhibitors. Coagulation factor VII human A coagulation factor used to treat bleeding disorders such as hemophilia and Glanzmann's thrombasthenia. Trenonacog alfa Human coagulation factor IX (EC 18.104.22.168, Christmas factor, plasma thromboplastin component), produced in CHO cells. Albutrepenonacog alfa A recombinant Factor IX fused to recombinant human albumin used to treat hemophilia B. Nonacog beta pegol A recombinant coagulation Factor IX derivative used to treat hemophilia B. Coagulation Factor IX Human A coagulation factor used to treat hemophilia B or factor IX hemophilia. Plasminogen Plasma-derived human plasminogen administered intravenously to treat type 1 plasminogen deficiency (hypoplasminogenemia).
- Drugs & Drug Targets